112 related articles for article (PubMed ID: 1438439)
1. The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft.
Noga SJ; Davis JM; Vogelsang GB; Donnenberg AD; Thoburn C; Schepers K; Sproul J
Prog Clin Biol Res; 1992; 377():411-8. PubMed ID: 1438439
[No Abstract] [Full Text] [Related]
2. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
Jansen J; Hanks S; English D; Karaffa R; Akard L
Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
[No Abstract] [Full Text] [Related]
3. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
[No Abstract] [Full Text] [Related]
4. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
[No Abstract] [Full Text] [Related]
5. Peanut agglutinin purging and magnetic microspheres.
Rhodes EG; Baker PK; Duguid JK; Cawley JC
Prog Clin Biol Res; 1992; 377():139-46. PubMed ID: 1438410
[No Abstract] [Full Text] [Related]
6. Prevention of graft-versus-host disease by using immunotoxins.
Laurent G; Bouloux C
Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
[No Abstract] [Full Text] [Related]
7. Campath-1M antibodies for T cell depletion of haploidentical marrow transplanted to children with malignant osteopetrosis.
Fasth A; Porras O; Baltorano A; Carrillo J; Gonzales L; Odio C; de los Angeles Umaña M
Prog Clin Biol Res; 1992; 377():399-403. PubMed ID: 1438436
[No Abstract] [Full Text] [Related]
8. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
9. T-cell depletion in unrelated bone marrow transplantation.
Tricot G
Semin Hematol; 1992 Apr; 29(2 Suppl 1):26-31; discussion 31-2. PubMed ID: 1615342
[No Abstract] [Full Text] [Related]
10. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
Morishima Y
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
[TBL] [Abstract][Full Text] [Related]
11. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody.
Rhodes EG; Baker PK; Duguid JK; Davies JM; Cawley JC
Bone Marrow Transplant; 1992 Dec; 10(6):485-9. PubMed ID: 1490198
[TBL] [Abstract][Full Text] [Related]
12. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
13. [Ex-vivo treatment of a bone marrow graft].
Bieva CJ
Rev Med Brux; 1992 May; 13(5):177-82. PubMed ID: 1609193
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
15. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
[TBL] [Abstract][Full Text] [Related]
16. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
[TBL] [Abstract][Full Text] [Related]
17. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
Uckun FM; Myers DE
J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
19. T-cell depletion and allogeneic bone marrow transplantation.
O'Reilly RJ
Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
[No Abstract] [Full Text] [Related]
20. Development of an immunomagnetic separation procedure to deplete V alpha beta-positive T cells from marrow for use in partially mismatched related donor (PMRD) transplantation.
Lamb L; Metherell J; Lee C; Brouillette M; Thompson J; Brown S; Henslee-Downey PJ; Gee A
Prog Clin Biol Res; 1994; 389():541-50. PubMed ID: 7700919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
